TET Family of Dioxygenases: Crucial Roles and Underlying Mechanisms

Cytogenetic and Genome Research

Volumn 146, Issue 3, 2015, Pages 171-180

  Li, Duo ^a,b   Guo, Bin ^b   Wu, Haijing ^a   Tan, Lina ^a   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

5 Hydroxymethylcytosine; Development; Differentiation; DNA demethylation; DNA methylation; Epigenetic therapy; GlcNAcylation; Histone modification; TET protein; Transformation

Indexed keywords

2 OXOGLUTARIC ACID; 5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; DIOXYGENASE; DNA; FERROUS ION; O LINKED BETA N ACETYLGLUCOSAMINE TRANSFERASE; PROTEIN; TEN ELEVEN TRANSLOCATION PROTEIN; TRANSFERASE; UNCLASSIFIED DRUG;

ACYLATION; CELL DIFFERENTIATION; CELL METABOLISM; DEMETHYLATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GENOMICS; METABOLISM; PHYSIOLOGY;

DIOXYGENASES; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENOMICS; HUMANS;

EID: 84948381421     PISSN: 14248581     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000438853     Document Type: Review

References (87)

1. Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J , et al: Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114: 144-147 (2009).
2. Arioka Y, Watanabe A, Saito K, Yamada Y: Activation-induced cytidine deaminase alters the subcellular localization of Tet family proteins. PloS One 7:e45031 (2012).
3. Asmar F, Punj V, Christensen J, Pedersen MT, Pedersen A , et al: Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica 98: 1912-1920 (2013).
4. Blaschke K, Ebata KT, Karimi MM, Zepeda-Martinez JA, Goyal P , et al: Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500: 222-226 (2013).
5. Bradley-Whitman MA, Lovell MA: Epigenetic changes in the progression of Alzheimer's disease. Mech Ageing Dev 134: 486-495 (2013).
6. Chen H, Dzitoyeva S, Manev H: Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus. Restor Neurol Neurosci 30: 237-245 (2012).
7. Chen Q, Chen Y, Bian C, Fujiki R, Yu X: TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493: 561-564 (2013).
8. Coskun V, Tsoa R, Sun YE: Epigenetic regulation of stem cells differentiating along the neural lineage. Curr Opin Neurobiol 22: 762-767 (2012).
9. Costa Y, Ding J, Theunissen TW, Faiola F, Hore TA , et al: NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 495: 370-374 (2013).
10. Dawlaty MM, Breiling A, Le T, Barrasa MI, Raddatz G , et al: Loss of Tet enzymes compromises proper differentiation of embryonic stem cells. Dev Cell 29: 102-111 (2014).
11. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S , et al: Mutation in TET2 in myeloid cancers. N Engl J Med 360: 2289-2301 (2009).
12. Deplus R, Delatte B, Schwinn MK, Defrance M, Mendez J , et al: TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J 32: 645-655 (2013).
13. Dickson KM, Gustafson CB, Young JI, Zuchner S, Wang G: Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate. Biochem Biophys Res Commun 439: 522-527 (2013).
14. Doege CA, Inoue K, Yamashita T, Rhee DB, Travis S , et al: Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488: 652-655 (2012).
15. Dong C, Zhang H, Xu C, Arrowsmith CH, Min J: Structure and function of dioxygenases in histone demethylation and DNA/RNA demethylation. IUCrJ 1: 540-549 (2014).
16. Dong E, Gavin DP, Chen Y, Davis J: Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry 2:e159 (2012).
17. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J , et al: Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18: 553-567 (2010).
18. Fong JJ, Nguyen BL, Bridger R, Medrano EE, Wells L , et al: Beta-N-acetylglucosamine (OGlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J Biol Chem 287: 12195-12203 (2012).
19. Fu X, Jin L, Wang X, Luo A, Hu J , et al: Micro-RNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation. Proc Natl Acad Sci USA 110: 17892-17897 (2013).
20. Fujiki R, Hashiba W, Sekine H, Yokoyama A, Chikanishi T , et al: GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 480: 557-560 (2011).
21. Gavin DP, Chase KA, Sharma RP: Active DNA demethylation in post-mitotic neurons: A reason for optimism. Neuropharmacology 75: 233-245 (2013).
22. Gu TP, Guo F, Yang H, Wu HP, Xu GF , et al: The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477: 606-610 (2011).
23. Hahn MA, Qiu R, Wu X, Li AX, Zhang H , et al: Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis. Cell Rep 3: 291-300 (2013).
24. Hashimoto H, Pais JE, Zhang X, Saleh L, Fu ZQ , et al: Structure of a Naegleria Tet-like dioxygenase in complex with 5-methylcytosine DNA. Nature 506: 391-395 (2014).
25. He YF, Li BZ, Li Z, Liu P, Wang Y , et al: Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333: 1303-1307 (2011).
26. Hu L, Li Z, Cheng J, Rao Q, Gong W , et al: Crystal structure of TET2-DNA complex: Insight into TET-mediated 5mC oxidation. Cell 155: 1545-1555 (2013).
27. Ichiyama K, Chen T, Wang X, Yan X, Kim BS , et al: The methylcytosine dioxygenase TET2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42: 613-626 (2015).
28. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC , et al: Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466: 1129-1133 (2010).
29. Ito S, Shen L, Dai Q, Wu SC, Collins LB , et al: Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333: 1300-1303 (2011).
30. Ivanov M, Kals M, Kacevska M, Barragan I, Kasuga K , et al: Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function. Genome Biol 14:R83 (2013).
31. Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M , et al: Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 113: 6403-6410 (2009).
32. Jin SG, Wu X, Li AX, Pfeifer GP: Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 39: 5015-5024 (2011).
33. Johnson AA, Akman K, Calimport SR, Wuttke D, Stolzing A, et al: The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res 15: 483-494 (2012).
34. Kizuka Y, Kitazume S, Okahara K, Villagra A, Sotomayor EM , et al: Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. J Biol Chem 289: 11253-11261 (2014).
35. Ko M, An J, Bandukwala HS, Chavez L, Aijo T , et al: Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 497: 122-126 (2013).
36. Kohli RM, Zhang Y: TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502: 472-479 (2013).
37. Kosmider O, Gelsi-Boyer V, Cheok M, Grabar S, Della-Valle V , et al: TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Blood 114: 3285-3291 (2009).
38. Kubiura M, Okano M, Kimura H, Kawamura F, Tada M: Chromosome-wide regulation of euchromatin-specific 5mC to 5hmC conversion in mouse ES cells and female human somatic cells. Chromosome Res 20: 837-848 (2012).
39. Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y , et al: Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 103: 670-676 (2012).
40. Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG , et al: Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 41: 838-842 (2009).
41. Lemonnier F, Couronne L, Parrens M, Jais JP, Travert M , et al: Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120: 1466-1469 (2012).
42. Li T, Yang D, Li J, Tang Y, Yang J, et al: Critical role of Tet3 in neural progenitor cell maintenance and terminal differentiation. Mol Neurobiol 51: 142-154 (2015).
43. Li Y, O'Neill C: 5-Methylcytosine and 5-hydroxymethylcytosine each provide epigenetic information to the mouse zygote. PloS One 8:e63689 (2013).
44. Li Z, Cai X, Cai CL, Wang J, Zhang W , et al: Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118: 4509-4518 (2011).
45. Lian CG, Xu Y, Ceol C, Wu F, Larson A , et al: Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150: 1135-1146 (2012).
46. Liu N, Wang M, Deng W, Schmidt CS, Qin W , et al: Intrinsic and extrinsic connections of Tet3 dioxygenase with CXXC zinc finger modules. PloS One 8:e62755 (2013).
47. Liu R, Jin Y, Tang WH, Qin L, Zhang X , et al: Teneleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation 128: 2047-2057 (2013).
48. Liu Y, Jiang W, Liu J, Zhao S, Xiong J , et al: IDH1 mutations inhibit multiple alpha-ketoglutarate-dependent dioxygenase activities in astroglioma. J Neurooncol 109: 253-260 (2012).
49. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E , et al: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560 (2007).
50. Minor EA, Court BL, Young JI, Wang G: Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J Biol Chem 288: 13669-13674 (2013).
51. Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D , et al: Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20: 11-24 (2011).
52. Nakamura T, Liu YJ, Nakashima H, Umehara H, Inoue K , et al: PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos. Nature 486: 415-419 (2012).
53. Neri F, Incarnato D, Krepelova A, Rapelli S, Pagnani A , et al: Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol 14:R91 (2013).
54. Neri F, Incarnato D, Krepelova A, Rapelli S, Anselmi F , et al: Single-base resolution analysis of 5-formyl and 5-carboxyl cytosine reveals promoter DNA methylation dynamics. Cell Rep doi:10.1016/j.celrep.2015.01.008 (2015).
55. Okashita N, Kumaki Y, Ebi K, Nishi M, Okamoto Y , et al: PRDM14 promotes active DNA demethylation through the ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells. Development 141: 269-280 (2014).
56. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian SE, Eberhart CG: Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PloS One 7:e41036 (2012).
57. Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R , et al: Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473: 394-397 (2011).
58. Prosdocimo DA, Jain R, Jain MK: UnTEThering (smooth muscle) cell plasticity. Circulation 128: 2002-2004 (2013).
59. Qian H, Xu X: Reduction in DNA methyltransferases and alteration of DNA methylation pattern associate with mouse skin ageing. Exp Dermatol 23: 357-359 (2014).
60. Quivoron C, Couronne L, Della Valle V, Lopez CK, Plo I , et al: TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20: 25-38 (2011).
61. Raiber EA, Beraldi D, Ficz G, Burgess HE, Branco MR , et al: Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol 13:R69 (2012).
62. Rose NR, McDonough MA, King ON, Kawamura A, Schofield CJ: Inhibition of 2-oxoglutarate dependent oxygenases. Chem Soc rev 40: 4364-4397 (2011).
63. Rudenko A, Dawlaty MM, Seo J, Cheng AW, Meng J , et al: Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 79: 1109-1122 (2013).
64. Shen L, Wu H, Diep D, Yamaguchi S, D'Alessio AC , et al: Genome-wide analysis reveals TETand TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153: 692-706 (2013).
65. Shim EH, Livi CB, Rakheja D, Tan J, Benson D , et al: L-2-Hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov 4: 1290-1298 (2014).
66. Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ , et al: Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153: 678-691 (2013).
67. Song SJ, Ito K, Ala U, Kats L, Webster K , et al: The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13: 87-101 (2013).
68. Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE: 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biology 12:R54 (2011).
69. Sui X, Price C, Li Z, Chen J: Crosstalk between DNA and histones: Tet's new role in embryonic stem cells. Curr Genomics 13: 603-608 (2012).
70. Sun Z, Dai N, Borgaro JG, Quimby A, Sun D , et al: A sensitive approach to map genome-wide 5-hydroxymethylcytosine and 5-formylcytosine at single-base resolution. Mol Cell 57: 750-761 (2015).
71. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H , et al: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935 (2009).
72. Valinluck V, Sowers LC: Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 67: 946-950 (2007).
73. Vella P, Scelfo A, Jammula S, Chiacchiera F, Williams K , et al: Tet proteins connect the Olinked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell 49: 645-656 (2013).
74. Wang T, Wu H, Li Y, Szulwach KE, Lin L , et al: Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat Cell Biol 15: 700-711 (2013).
75. Williams K, Christensen J, Helin K: DNA methylation: TET proteins-guardians of CpG islands EMBO Rep 13: 28-35 (2012).
76. Wossidlo M, Nakamura T, Lepikhov K, Marques CJ, Zakhartchenko V , et al: 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat Commun 2: 241 (2011).
77. Wu H, Zhang Y: Tet1 and 5-hydroxymethylation: A genome-wide view in mouse embryonic stem cells. Cell Cycle 10: 2428-2436 (2011).
78. Wu H, D'Alessio AC, Ito S, Wang Z, Cui K , et al: Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 25: 679-684 (2011).
79. Wu Y, Guo Z, Liu Y, Tang B, Wang Y , et al: Oct4 and the small molecule inhibitor, SC1, regulates Tet2 expression in mouse embryonic stem cells. Mol Biol Rep 40: 2897-2906 (2013).
80. Xu Y, Wu F, Tan L, Kong L, Xiong L , et al: Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 42: 451-464 (2011).
81. Yamaguchi S, Hong K, Liu R, Inoue A, Shen L , et al: Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Res 23: 329-339 (2013a).
82. Yamaguchi S, Shen L, Liu Y, Sendler D, Zhang Y: Role of Tet1 in erasure of genomic imprinting. Nature 504: 460-464 (2013b).
83. Yang H, Liu Y, Bai F, Zhang JY, Ma SH , et al: Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32: 663-669 (2013).
84. Yang Q, Wu K, Ji M, Jin W, He N , et al: Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients. J Biomed Nanotechnol 9: 1607-1616 (2013).
85. Yin R, Mao SQ, Zhao B, Chong Z, Yang Y , et al: Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc 135: 10396-10403 (2013).
86. Zhang P, Huang B, Xu X, Sessa WC: Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a. Biochem Biophys Res Commun 437: 368-373 (2013).
87. Zhang S, Roche K, Nasheuer HP, Lowndes NF: Modification of histones by sugar beta-Nacetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem 286: 37483-37495 (2011).